NCT02708576View on ClinicalTrials.gov

Phase 1 Study of NGM313 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Obesity
Interventions
BIOLOGICAL

NGM313

OTHER

Placebo

Trial Locations (1)

Unknown

NGM Clinical Study Site, Melbourne

Sponsors
All Listed Sponsors
lead

NGM Biopharmaceuticals, Inc

INDUSTRY

NCT02708576 - Phase 1 Study of NGM313 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter